XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 248,142 $ 209,764 $ 500,727 $ 374,614
Costs and expenses:        
Cost of revenue 43,886 38,736 89,074 74,719
Research and development 41,041 30,525 78,749 56,882
Selling, general and administrative 102,779 79,167 206,263 147,611
Acquired in-process research and development     115,490  
Costs and Expenses, Total 187,706 148,428 489,576 279,212
Operating income 60,436 61,336 11,151 95,402
Other income:        
Investment income, net 977 1,822 2,027 4,219
Other income, net 5,858 9,757 44,743 34,370
Nonoperating Income (Expense), Total 6,835 11,579 46,770 38,589
Income before income taxes 67,271 72,915 57,921 133,991
Income tax provision 10,318 10,702 27,493 27,190
Net income $ 56,953 $ 62,213 $ 30,428 $ 106,801
Net income per share - basic $ 1.25 $ 1.38 $ 0.67 $ 2.37
Weighted average shares outstanding - basic 45,437 45,104 45,374 45,057
Net income per share - diluted $ 1.24 $ 1.36 $ 0.66 $ 2.34
Weighted average shares outstanding - diluted 45,893 45,661 45,857 45,609